ArticleBMC cancer2025

Comparative efficacy and safety of immune checkpoint inhibitors combined with antiangiogenic agents for unresectable hepatocellular carcinoma in patients with Child-Pugh A versus B cirrhosis: a single-center, retrospective study.

Dan Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.